FFA
VIR icon

Farther Finance Advisors’s Vir Biotechnology VIR Stock Holding History

Farther Finance Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.44K Sell
397
-241
-38% -$2.41K ﹤0.01% 5079
2026
Q2 		$6.5K Buy
638
+71
+13% +$675 ﹤0.01% 4653
2026
Q1 		$5.11K Buy
567
+514
+970% +$4.1K ﹤0.01% 4481
2025
Q4 		$320 Buy
53
+4
+8% +$24 ﹤0.01% 5122
2025
Q3 		$280 Sell
49
-135
-73% -$690 ﹤0.01% 4654
2025
Q2 		$927 Buy
+184
New +$987 ﹤0.01% 3921
2024
Q4 		– Sell
-485
Closed -$3.63K – 4158
2024
Q3 		$3.63K Buy
485
+60
+14% +$521 ﹤0.01% 2776
2024
Q2 		$3.87K Sell
425
-31
-7% -$297 ﹤0.01% 2508
2024
Q1 		$4.65K Buy
456
+26
+6% +$265 ﹤0.01% 2101
2023
Q4 		$4.33K Sell
430
-11
-2% -$101 ﹤0.01% 2042
2023
Q3 		$4.13K Buy
+441
New +$6.29K ﹤0.01% 1580

Other funds holding VIR

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's VIR Position: Q3 2026 in Review

Farther Finance Advisors reduced its Vir Biotechnology (VIR) stake by 38% in Q3 2026, selling an estimated $2.41K and leaving 397 shares worth $4.44K. The position accounts for ﹤0.01% of the portfolio, ranked #5079.

Farther Finance Advisors first reported a position in VIR in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.5K in Q2 2026. 6 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Farther Finance Advisors held 397 shares of Vir Biotechnology worth $4.44K as of Q3 2026.
  • Farther Finance Advisors sold 241 Vir Biotechnology shares in Q3 2026, an estimated $2.41K.
  • Vir Biotechnology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5079 holding.
  • Farther Finance Advisors first reported a position in Vir Biotechnology in Q3 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Vir Biotechnology position peaked at $6.5K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.